Linqi Li,1 Jing Cao,2 Jiao Qin,2 Xiangxiang Chen,2 Feng Yuan,2 Ping Deng,2,* Hebin Xie1,2,* 

1School of Public Health, University of South China, Heng Yang, Hunan, People’s Republic of China; 2The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Hebin Xie, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China, Tel +86 15173132201, Email 2018050642@usc.edu.cn

Purpose: To analyze the factors affecting patients’ prognoses based on the community acquired-bloodstream infection patient data from 2017 to 2021.
Patients and Methods: The data of 940 patients were retrieved, having at least one positive bilateral blood culture within 48 hours of hospitalization, and grouped into survivor and non-survivor groups. The clinical characteristics, laboratory results, causative pathogen and other indicators were collected and compared, and risk factors were identified by applying Cox proportional hazard regression model to the data.
Results: Community acquired-bloodstream infection is most commonly caused by Escherichia coli, Klebsiella species and Staphylococcus hominis. Among the total of 940 selected patients, 52 (5.5%) died during hospitalization. The demographic parameters like age and gender, clinical protocols like maintenance hemodialysis, glucocorticoid use during hospitalization, catheter placement, procaicitonin, total protein, albumin, creatinine, uric acid contents and Sequential Organ Failure Assessment scores were significantly different between the survivor and non-survivor groups. The survival analysis results revealed that age (HR=1.02, 95% CI: 1.00– 1.05, P=0.002), glucocorticoid use during hospitalization (HR=3.69, 95% CI: 1.62– 8.37, P=0.021) and Sequential Organ Failure Assessment score (HR=1.10, 95% CI: 1.03– 1.18, P=0.004) might be the risk factors affecting 30-day mortality in patients with community acquired-bloodstream infection.
Conclusion: The identified risk factors may help guide clinical treatment protocol for patients with community acquired-bloodstream infection, providing more effective treatment strategy selection with improved clinical outcomes.

Keywords: prognosis, pathogen, clinical characteristics, treatment